New Study: Vaccine Enhances Breast Cancer Treatment

Oncotarget | October 27, 2021
Researchers conducted a study to examine the efficacy of adding the P10s-PADRE vaccine to chemotherapy treatments for patients with HR+/HER2− breast cancer. continue reading »

Table of Contents: Oncotarget’s Volume 12, Issue #22

Oncotarget | October 26, 2021
Read short summaries of the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 22. continue reading »

EMT Resistance in Cancer Cells and Two Potential Causes

Oncotarget | October 21, 2021
Researchers used mathematical modeling to investigate mechanisms that drive the elusive phenomenon of cancer cell resistance to epithelial-mesenchymal transition (EMT). continue reading »

Trending With Impact: Green Tea Enhances Fitness and Lifespan in Worms

Aging | October 21, 2021
The mechanisms and pathways involved in the health and aging benefits conveyed by green tea were investigated in C. elegans. continue reading »

Trending With Impact: Retired Sled Dogs in Aging Research

Aging | October 14, 2021
Researchers adopted 103 retired sled dogs for a longitudinal study on canine aging that may one day be used to increase human healthspan and longevity. continue reading »

Behind the Study: Alzheimer’s as a Systems Network Disorder

Aging | October 11, 2021
Dr. Dale Bredesen from UCLA describes his research that was published by Aging (Aging-US) in 2020, entitled, “Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics.” continue reading »

Behind the Study: Alzheimer’s as a Systems Network Disorder

Spotlight | October 11, 2021
Dr. Dale Bredesen from UCLA describes his research that was published by Aging (Aging-US) in 2020, entitled, “Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics.” continue reading »

Behind the Study: Populations of Cells Resistant to EMT

Spotlight | September 27, 2021
Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that was published by Oncotarget on July 7, 2020, entitled, “Epigenetic feedback and stochastic partitioning during cell division can drive resistance to EMT.” continue reading »

Behind the Study: Evaluations in TRAMP Prostate Cancer Model

Spotlight | September 20, 2021
Dr. Yves Chabu from the University of Missouri describes a research paper he co-authored in 2020 that was published by Oncotarget, entitled, “Evaluations of CRC2631 toxicity, tumor colonization, and genetic stability in the TRAMP prostate cancer model.” continue reading »

Dr. Dale Bredesen – UCLA & The Buck Institute for Research on Aging

Testimonials | September 17, 2021
“So, there are many journals now that are open access, but that are not on PubMed. So having all those boxes checked, made it very, very important, and this is the reason that we have repeatedly published in Aging and Oncotarget” continue reading »

Dr. Yves Chabu – University of Missouri

Testimonials | September 17, 2021
“I just felt like they were responsive from when we submitted a manuscript to when we got the reviews back. And I also think that the chief editor was very reasonable, and I just wish that many other journals would actually do that.” continue reading »

Dr. Tapasree Roy Sarkar – Texas A&M University

Testimonials | September 8, 2021
"Generally, they really want to have a very solid and very effective research work. So whatever reviews that I have received previously also, it really helped to make the paper a better paper or a very nice paper" continue reading »

Press Release: Aging’s Latest Impact Factor

News | August 20, 2021
In June 2021, Web of Science (Clarivate Analytics) released their 2020 JCR Impact Factor. Aging is pleased to report that our 2020 impact factor is 5.682. continue reading »

Captain of Team Open Access Rides Again for Cancer Research

News | August 18, 2021
Sponsored by Impact Journals, Team Open Access is once again captained by Sergei Kurenov who explains his motivation to participate in the Ride for Roswell. continue reading »

The Ride for Roswell: Rolling Around The Track August 7

News | July 28, 2021
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York. continue reading »